The GLP-1 weight loss journey in India is gaining momentum as more people turn to science-backed solutions to tackle obesity and related metabolic conditions. These journeys often begin after years of struggling with weight through diet and exercise alone, especially for individuals with insulin resistance, PCOS, or type 2 diabetes. GLP-1 medications like semaglutide (Rybelsus, Wegovy) and tirzepatide (Mounjaro) help by reducing appetite, improving satiety, and supporting blood sugar control, leading to gradual but sustainable weight loss.